New Hantavirus Research Reagents Boost Diagnostic Development

Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, has announced its comprehensive Hantavirus Research Reagents and Products catalog. This new offering is designed to support researchers, biopharmaceutical companies, and industrial organizations in accelerating the development of diagnostic assays and therapeutic interventions targeting dangerous rodent-borne orthohantaviruses. Hantaviruses are emerging zoonotic pathogens classified as Category A agents by the CDC, causing highly fatal diseases such as hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). The pathogens are transmitted to humans via aerosols from infected rodent excreta.

Hantaviruses have a tripartite negative-strand RNA genome encoding the nucleocapsid protein (N), envelope glycoproteins (Gn and Gc), and RNA-dependent RNA polymerase (RdRp). The N protein plays a crucial role in protecting viral RNA and facilitating transcription and replication. With no approved antiviral therapies or vaccines available, understanding the molecular mechanisms of hantavirus infection is critical for developing treatments. Early diagnosis is challenging due to symptoms resembling common respiratory illnesses, underscoring the need for sensitive and reliable diagnostic tools.

Creative Diagnostics' product line includes recombinant antigens, high-affinity monoclonal and polyclonal antibodies validated for Western blot, flow cytometry, immunohistochemistry, and surface plasmon resonance, as well as supporting reagents for ELISA and rapid immunoassays. The catalog covers multiple strains, including Hantavirus, Puumala virus, Seoul virus, and Sin Nombre virus. For detailed specifications, visit the official product portal. This launch positions Creative Diagnostics as a trusted partner in the fight against hantavirus diseases, providing critical tools for research and diagnostic development.